Notably, EpCAM BiTE induces CD4+ and CD8+ T-cell activation in the presence of EpCAM-positive tumor cells, like 4T1 and MC38-EpCAM, but not EpCAM-negative tumor cells, such as H22 and MC38. Here, CD4 is linked to neoplasm.